1. Invitrogen Reorganizes in Attempt to Better Connect With Customers (from Dec. 6)
2. Ciphergen Misled Investors, Class-Action Suit Alleges; Shares Slide 9 Percent (from Dec. 6)
3. Why One Sequencer Is Never Enough: NHGRI Official Says Demand for Varied Read Lengths May Define New Market (from Dec. 5)
4. Applied Biosystems, Qiagen Ink PCR Licensing Deal (from Dec. 5)
5. 454, WashU Pen Sequencing, Gene-Expression Alliance (from Dec. 7)